Ploy N. Pratanwanich

Ploy N. Pratanwanich


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
GKGautier Koscielny
Gautier Koscielny
PAPeter An
Peter An
DCDenise Carvalho-Silva
Denise Carvalho-Silva
JCJennifer A. Cham
Jennifer A. Cham
LFLuca Fumis
Luca Fumis
IDIan Dunham
Ian Dunham
We have designed and developed a data integration and visualization platform that provides evidence about the association of known and potential drug targets with diseases. The platform is designed to support identification and prioritization of biological targets for follow-up. Each drug target is linked to a disease using integrated genome-wide data from a broad range of data sources. The platform provides either a target-centric workflow to identify diseases that may be associated with a specific target, or a disease-centric workflow to identify targets that may be associated with a specific disease. Users can easily transition between these target- and disease-centric workflows. The Open Targets Validation Platform is accessible at https://www.targetvalidation.org.

19 July 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
PPPloy N. Pratanwanich
Ploy N. Pratanwanich
FYFei Yao
Fei Yao
YCYing Chen
Ying Chen
CKCasslynn W. Q. Koh
Casslynn W. Q. Koh
YWYuk Kei Wan
Yuk Kei Wan
JGJonathan Göke
Jonathan Göke

13 March 2025 in Nature Methods
Verified
Journal Article
Open access
PDF file
YCYing Chen
Ying Chen
NDNadia M. Davidson
Nadia M. Davidson
YWYuk Kei Wan
Yuk Kei Wan
FYFei Yao
Fei Yao
YSYan Su
Yan Su
JGJonathan Göke
Jonathan Göke
The human genome contains instructions to transcribe more than 200,000 RNAs. However, many RNA transcripts are generated from the same gene, resulting in alternative isoforms that are highly similar and that remain difficult to quantify. To evaluate the ability to study RNA transcript expression, we profiled seven human cell lines with five different RNA-sequencing protocols, including short-read cDNA, Nanopore long-read direct RNA, amplification-free direct cDNA and PCR-amplified cDNA sequencing, and PacBio IsoSeq, with multiple spike-in controls, and additional transcriptome-wide N 6-methyladenosine profiling data. We describe differences in read length, coverage, throughput and transcript expression, reporting that long-read RNA sequencing more robustly identifies major isoforms. We illustrate the value of the SG-NEx data to identify alternative isoforms, novel transcripts, fusion transcripts and N 6-methyladenosine RNA modifications. Together, the SG-NEx data provide a comprehensive resource enabling the development and benchmarking of computational methods for profiling complex transcriptional events at isoform-level resolution.

7 November 2017 in Genome Biology
Verified
Journal Article
Open access
PDF file
FBFlorian Buettner
Florian Buettner
PPPloy N. Pratanwanich
Ploy N. Pratanwanich
DMDavis J. McCarthy
Davis J. McCarthy
JMJohn C. Marioni
John C. Marioni
OSOliver Stegle
Oliver Stegle
Single-cell RNA-sequencing (scRNA-seq) allows studying heterogeneity in gene expression in large cell populations. Such heterogeneity can arise due to technical or biological factors, making decomposing sources of variation difficult. We here describe f-scLVM (factorial single-cell latent variable model), a method based on factor analysis that uses pathway annotations to guide the inference of interpretable factors underpinning the heterogeneity. Our model jointly estimates the relevance of individual factors, refines gene set annotations, and infers factors without annotation. In applications to multiple scRNA-seq datasets, we find that f-scLVM robustly decomposes scRNA-seq datasets into interpretable components, thereby facilitating the identification of novel subpopulations.

27 April 2015 in ACS Synthetic Biology
Verified
Journal Article
Open access
Claudio AngioneClaudio Angione
Claudio Angione
PPPloy N. Pratanwanich
Ploy N. Pratanwanich
PLPietro Lio
Pietro Lio
The growing availability of multiomic data provides a highly comprehensive view of cellular processes at the levels of mRNA, proteins, metabolites, and reaction fluxes. However, due to probabilistic interactions between components depending on the environment and on the time course, casual, sometimes rare interactions may cause important effects in the cellular physiology. To date, interactions at the pathway level cannot be measured directly, and methodologies to predict pathway cross-correlations from reaction fluxes are still missing. Here, we develop a multiomic approach of flux-balance analysis combined with Bayesian factor modeling with the aim of detecting pathway cross-correlations and predicting metabolic pathway activation profiles. Starting from gene expression profiles measured in various environmental conditions, we associate a flux rate profile with each condition. We then infer pathway cross-correlations and identify the degrees of pathway activation with respect to the conditions and time course using Bayesian factor modeling. We test our framework on the most recent metabolic reconstruction of Escherichia coli in both static and dynamic environments, thus predicting the functionality of particular groups of reactions and how it varies over time. In a dynamic environment, our method can be readily used to characterize the temporal progression of pathway activation in response to given stimuli.

17 February 2022 in Sensors
Verified
Journal Article
Open access
PDF file
PKPimarn Kantithammakorn
Pimarn Kantithammakorn
PPProadpran Punyabukkana
Proadpran Punyabukkana
PPPloy N. Pratanwanich
Ploy N. Pratanwanich
SHSolaphat Hemrungrojn
Solaphat Hemrungrojn
CCChaipat Chunharas
Chaipat Chunharas
DWDittaya Wanvarie
Dittaya Wanvarie
The Montreal cognitive assessment (MoCA), a widely accepted screening tool for identifying patients with mild cognitive impairment (MCI), includes a language fluency test of verbal functioning; its scores are based on the number of unique correct words produced by the test taker. However, it is possible that unique words may be counted differently for various languages. This study focuses on Thai as a language that differs from English in terms of word combinations. We applied various automatic speech recognition (ASR) techniques to develop an assisted scoring system for the MoCA language fluency test with Thai language support. This was a challenge because Thai is a low-resource language for which domain-specific data are not publicly available, especially speech data from patients with MCIs. Furthermore, the great variety of pronunciation, intonation, tone, and accent of the patients, all of which might differ from healthy controls, bring more complexity to the model. We propose a hybrid time delay neural network hidden Markov model (TDNN-HMM) architecture for acoustic model training to create our ASR system that is robust to environmental noise and to the variation of voice quality impacted by MCI. The LOTUS Thai speech corpus was incorporated into the training set to improve the model’s generalization. A preprocessing algorithm was implemented to reduce the background noise and improve the overall data quality before feeding data into the TDNN-HMM system for automatic word detection and language fluency score calculation. The results show that the TDNN-HMM model in combination with data augmentation using lattice-free maximum mutual information (LF-MMI) objective function provides a word error rate (WER) of 30.77%. To our knowledge, this is the first study to develop an ASR with Thai language support to automate the scoring system of MoCA’s language fluency assessment.